DCF — SWEDISH COVENANT HEALTH
Enterprise Value: $-259.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-259.0M
Enterprise Value
$-89.1M
PV of Cash Flows
$-169.9M
PV of Terminal Value
$-273.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $374.4M | $-12.2M | -3.0% | $-28.1M | $-25.5M |
| Year 2 | $385.7M | $-8.8M | -2.0% | $-25.1M | $-20.7M |
| Year 3 | $397.2M | $-5.0M | -1.0% | $-21.9M | $-16.4M |
| Year 4 | $409.1M | $-3.1M | -1.0% | $-20.5M | $-14.0M |
| Year 5 | $421.4M | $-2.2M | -1.0% | $-20.0M | $-12.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-259.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$363.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.037692223230245264
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5